Alar Pharmaceuticals Inc. (6785.TWO)
TWD 138.5
(-1.07%)
TWD 138.5
(-1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 469.27 Million | 800 Thousand | - | 600 Thousand | - |
| Cost of Revenue | 3.35 Million | - | - | - | 3.14 Million |
| Gross Profit | 465.92 Million | 800 Thousand | - | 600 Thousand | -3.14 Million |
| Operating Expenses | 83.74 Million | 47.32 Million | 93.29 Million | 171.36 Million | 61.38 Million |
| Selling, General and Administrative Expenses | 27.03 Million | 13.14 Million | 11.4 Million | 11.03 Million | 6.2 Million |
| Research and Development Expenses | 56.71 Million | 34.18 Million | 81.88 Million | 160.32 Million | 55.18 Million |
| Other Expenses | - | 9.55 Million | 27.52 Million | 26.27 Million | - |
| Cost and Expenses | 83.74 Million | 47.32 Million | 93.29 Million | 171.36 Million | 61.38 Million |
| Operating Income | 385.52 Million | -32.51 Million | -64.21 Million | -142.76 Million | -61.38 Million |
| Interest Expense | 63 Thousand | 22 Thousand | 21 Thousand | 33 Thousand | - |
| Income Tax Expense | 8.49 Million | -12.66 Million | - | - | - |
| Earnings before Tax | 391.1 Million | -32.53 Million | -64.23 Million | -142.79 Million | -67.97 Million |
| Net Income | 382.61 Million | -19.87 Million | -64.23 Million | -142.79 Million | -67.97 Million |
| Earnings Per Share Basic | 6.71 | -0.35 | -1.13 | -2.86 | -1.94 |
| Earnings Per Share Diluted | 6.71 | -0.35 | -1.13 | -2.86 | -1.94 |
| Weighted Average Shares Outstanding | 57 Million | 57 Million | 57 Million | 49.9 Million | 35 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.05 Million | 57 Million | 57 Million | 49.9 Million | 35 Million |
| Gross Margin | 0.99 | 1.00 | - | 1.00 | - |
| EBIT Margin | 0.84 | -36.64 | - | -233.20 | - |
| Profit Margin | 0.82 | -24.84 | - | -238.00 | - |
| EBITDA | 394.52 Million | -29.31 Million | -60.85 Million | -139.92 Million | -59.09 Million |
| Earnings Before Tax Margin | 0.82 | -40.64 | - | -237.94 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 468.47 Million | 469.27 Million | 800 Thousand | - |
| Cost of Revenue | 948 Thousand | - | - | - | - | - |
| Gross Profit | -948 Thousand | - | 468.47 Million | 469.27 Million | 800 Thousand | - |
| Operating Expenses | 16.94 Million | 22.1 Million | 33.92 Million | 83.74 Million | 14.32 Million | 18.99 Million |
| Selling, General and Administrative Expenses | 2.9 Million | 3.97 Million | 14.38 Million | - | 2.76 Million | 3.29 Million |
| Research and Development Expenses | 14.04 Million | 18.13 Million | 19.53 Million | - | 11.56 Million | 15.7 Million |
| Other Expenses | 21 Thousand | 57 Thousand | 28 Thousand | 44 Thousand | 8000.00 | 2000.00 |
| Cost and Expenses | 16.94 Million | 22.1 Million | 33.92 Million | 83.74 Million | 14.32 Million | 18.99 Million |
| Operating Income | 8.15 Million | 17.77 Million | 415.93 Million | 391.16 Million | 1.06 Million | -8.66 Million |
| Interest Expense | 7000.00 | 10 Thousand | 12 Thousand | 63 Thousand | 14 Thousand | 17 Thousand |
| Income Tax Expense | 11.69 Million | 5.71 Million | 8.49 Million | 8.49 Million | -678 Thousand | 1.25 Million |
| Earnings before Tax | 8.15 Million | 17.76 Million | 415.92 Million | 391.1 Million | 1.05 Million | -8.68 Million |
| Net Income | -3.54 Million | 12.04 Million | 407.43 Million | 382.61 Million | 1.73 Million | -9.93 Million |
| Earnings Per Share Basic | -0.05 | 0.19 | 7.10 | - | 0.03 | -0.17 |
| Earnings Per Share Diluted | -0.05 | 0.19 | 7.10 | - | 0.03 | -0.17 |
| Weighted Average Shares Outstanding | 70.86 Million | 64.43 Million | 57.36 Million | 57 Million | 57.73 Million | 58.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.86 Million | 64.45 Million | 57.39 Million | 57.05 Million | 57.73 Million | 58.42 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | - | - | 0.89 | - | 2.45 | - |
| Profit Margin | - | - | 0.87 | 0.82 | 2.16 | - |
| EBITDA | 9.1 Million | 18.68 Million | 416.83 Million | - | 1.95 Million | -7.84 Million |
| Earnings Before Tax Margin | - | - | 0.89 | 0.83 | 1.34 | - |
1802
YOU
ACGL
CLVSF
3631
RIOT